Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB26FDSTT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,652
Award facts
- Contract value 100% obligated
- $41,652.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, valued at $41,652.45. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical federal pharmaceutical distributor supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company maintains an extensive portfolio of brand-name and generic medications across multiple therapeutic domains, with prior contract awards demonstrating delivery of specialty pharmaceuticals, vaccines, and medical supplies. This particular delivery order for Ozempic, a diabetes management medication, reflects AmerisourceBergen's ongoing role in providing essential pharmaceutical commodities to support Defense Health Agency and broader federal healthcare requirements. The non-set-aside competitive award demonstrates the company's capability to meet federal procurement standards through open competition.
Quick answers
Who was awarded contract SPE2DB26FDSTT?
SPE2DB26FDSTT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FDSTT worth?
The government has obligated $41,652 on SPE2DB26FDSTT.
Is contract SPE2DB26FDSTT an order under another contract?
Yes. SPE2DB26FDSTT is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB26FDSTT competed?
The extent of competition for SPE2DB26FDSTT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award